Patent: 6,814,966
✉ Email this page to a colleague
Summary for Patent: 6,814,966
Title: | Methods for treating glaucoma |
Abstract: | This invention provides a method for treating a subject with glaucoma comprising the steps of administrating a compound or composition which antagonize, inhibits, inactivates, reduce, suppresses, antagonizes, and/or limits the release, synthesis, or production from cells of TNF-.alpha. thereby treating the subject with glaucoma. |
Inventor(s): | Wax; Martin B. (Wildwood, MO), Tezel; Gulgun (Louisville, KY) |
Assignee: | Pharmacia Corporation (St. Louis, MO) |
Application Number: | 09/591,561 |
Patent Claims: | see list of patent claims |
Details for Patent 6,814,966
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2020-02-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |